Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1147 | 1094 | 1193 | 1144 | 1762 | 2473 |
Fund Return | 14.73% | 9.37% | 19.32% | 4.59% | 11.99% | 9.48% |
Place in category | 441 | 503 | 249 | 141 | 70 | 55 |
% in Category | 45 | 48 | 29 | 25 | 15 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Growth Portfolio B Ace | 8.21B | 16.65 | 3.66 | 13.17 | ||
AB FCP IAmericanGrwthPf C EUR H Acc | 8.17B | 15.77 | 1.72 | 11.64 | ||
AB FCP IAmericanGrwthPf A EUR H Acc | 8.17B | 16.12 | 2.18 | 12.15 | ||
AB FCP IAmericanGrwthPf I EUR H Acc | 8.17B | 16.73 | 3.00 | 13.03 | ||
Japan Strategic Value Portfolio S1e | 7.05B | 17.43 | 2.82 | 8.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund A2e | 7.36B | 16.97 | 4.69 | 9.34 | ||
World Healthscience Fund E2e | 2.37B | 16.58 | 4.17 | 8.79 | ||
LU1960219571 | 1.67B | 17.77 | 5.72 | - | ||
LU2112291799 | 833.17M | 17.02 | 4.70 | - | ||
World Healthscience Fund C2e | 418.21M | 16.02 | 3.39 | 7.98 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.20 | 930.03 | +1.64% | |
UnitedHealth | US91324P1021 | 8.23 | 574.69 | -0.41% | |
Novo Nordisk B | DK0062498333 | 7.93 | 850.0 | -5.37% | |
Merck&Co | US58933Y1055 | 6.25 | 117.30 | +0.06% | |
Roche Holding Participation | CH0012032048 | 5.87 | 269.30 | +0.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review